These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38920352)

  • 1. PLGA-LEC/F127 hybrid nanoparticles loaded with curcumin and their modulatory effect on monocytes.
    T Cruz J; Karen Álvarez ; H Orozco V; Mauricio Rojas ; A Morales-Luckie R; F Giraldo L
    Nanomedicine (Lond); 2024 Jun; 19(15):1407-1423. PubMed ID: 38920352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
    Godara S; Lather V; Kirthanashri SV; Awasthi R; Pandita D
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110576. PubMed ID: 32228957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
    Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
    Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells.
    Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P
    Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
    Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
    J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
    Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
    AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
    Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
    Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
    Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
    Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
    Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.
    Mayol L; Serri C; Menale C; Crispi S; Piccolo MT; Mita L; Giarra S; Forte M; Saija A; Biondi M; Mita DG
    Eur J Pharm Biopharm; 2015 Jun; 93():37-45. PubMed ID: 25794477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
    Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
    J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA nanoparticles loaded with curcumin produced luminescence for cell bioimaging.
    Wang R; Zou L; Yi Z; Zhang Z; Zhao M; Shi S
    Int J Pharm; 2023 May; 639():122944. PubMed ID: 37044226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate.
    Horváti K; Gyulai G; Csámpai A; Rohonczy J; Kiss É; Bősze S
    Bioconjug Chem; 2018 May; 29(5):1495-1499. PubMed ID: 29669198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
    Vakilinezhad MA; Amini A; Dara T; Alipour S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.
    Turk CT; Oz UC; Serim TM; Hascicek C
    AAPS PharmSciTech; 2014 Feb; 15(1):161-76. PubMed ID: 24222270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.